COL10A1 is thus a valuable biomarker for CAF-mediated ECM remodeling, immunosuppression, inflammation, and induction of invasion in breast and pancreatic tumors; future work will further elucidate its complex roles across diverse CAF and cancer types. This evidence concerns the gene COL10A1 and cancer.